These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35563373)

  • 1. The PDE4 Inhibitor Tanimilast Restrains the Tissue-Damaging Properties of Human Neutrophils.
    Schioppa T; Nguyen HO; Salvi V; Maugeri N; Facchinetti F; Villetti G; Civelli M; Gaudenzi C; Passari M; Sozio F; Barbazza I; Tamassia N; Cassatella MA; Del Prete A; Bosisio D; Tiberio L
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PDE4 Inhibitor Tanimilast Blunts Proinflammatory Dendritic Cell Activation by SARS-CoV-2 ssRNAs.
    Nguyen HO; Schioppa T; Tiberio L; Facchinetti F; Villetti G; Civelli M; Del Prete A; Sozio F; Gaudenzi C; Passari M; Barbazza I; Sozzani S; Salvi V; Bosisio D
    Front Immunol; 2021; 12():797390. PubMed ID: 35140709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The modulatory effects of the PDE4 inhibitors CHF6001 and roflumilast in alveolar macrophages and lung tissue from COPD patients.
    Lea S; Metryka A; Li J; Higham A; Bridgewood C; Villetti G; Civelli M; Facchinetti F; Singh D
    Cytokine; 2019 Nov; 123():154739. PubMed ID: 31319374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PDE4 inhibitor tanimilast shows distinct immunomodulatory properties associated with a type 2 endotype and CD141 upregulation.
    Nguyen HO; Salvi V; Tiberio L; Facchinetti F; Govoni M; Villetti G; Civelli M; Barbazza I; Gaudenzi C; Passari M; Schioppa T; Sozio F; Del Prete A; Sozzani S; Bosisio D
    J Transl Med; 2022 May; 20(1):203. PubMed ID: 35538539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PDE4 inhibitor CHF6001 modulates pro-inflammatory cytokines, chemokines and Th1- and Th17-polarizing cytokines in human dendritic cells.
    Gianello V; Salvi V; Parola C; Moretto N; Facchinetti F; Civelli M; Villetti G; Bosisio D; Sozzani S
    Biochem Pharmacol; 2019 May; 163():371-380. PubMed ID: 30851246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD.
    Singh D; Beeh KM; Colgan B; Kornmann O; Leaker B; Watz H; Lucci G; Geraci S; Emirova A; Govoni M; Nandeuil MA
    Respir Res; 2019 Aug; 20(1):180. PubMed ID: 31399091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory effects of the phosphodiesterase type 4 inhibitor CHF6001 on bronchoalveolar lavage lymphocytes from asthma patients.
    Southworth T; Kaur M; Hodgson L; Facchinetti F; Villetti G; Civelli M; Singh D
    Cytokine; 2019 Jan; 113():68-73. PubMed ID: 29934047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis.
    Govoni M; Bassi M; Vezzoli S; Lucci G; Emirova A; Nandeuil MA; Petruzzelli S; Jellema GL; Afolabi EK; Colgan B; Leaker B; Kornmann O; Beeh KM; Watz H; Singh D
    Respir Res; 2020 Mar; 21(1):72. PubMed ID: 32197620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease.
    Facchinetti F; Civelli M; Singh D; Papi A; Emirova A; Govoni M
    Front Pharmacol; 2021; 12():740803. PubMed ID: 34887752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NETopathic Inflammation in Chronic Obstructive Pulmonary Disease and Severe Asthma.
    Uddin M; Watz H; Malmgren A; Pedersen F
    Front Immunol; 2019; 10():47. PubMed ID: 30804927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of selective phosphodiesterase isoenzyme inhibition on neutrophil function in vitro.
    Jones NA; Boswell-Smith V; Lever R; Page CP
    Pulm Pharmacol Ther; 2005; 18(2):93-101. PubMed ID: 15649851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Neutrophil Extracellular Traps in Asthma and Chronic Obstructive Pulmonary Disease.
    Liu T; Wang FP; Wang G; Mao H
    Chin Med J (Engl); 2017 Mar; 130(6):730-736. PubMed ID: 28303858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taurine chloramine selectively regulates neutrophil degranulation through the inhibition of myeloperoxidase and upregulation of lactoferrin.
    Kim DG; Kwon YM; Kang IS; Kim C
    Amino Acids; 2020 Aug; 52(8):1191-1199. PubMed ID: 32865666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study.
    Singh D; Emirova A; Francisco C; Santoro D; Govoni M; Nandeuil MA
    Respir Res; 2020 Sep; 21(1):246. PubMed ID: 32962709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase 4 inhibitors delay human eosinophil and neutrophil apoptosis in the absence and presence of salbutamol.
    Parkkonen J; Hasala H; Moilanen E; Giembycz MA; Kankaanranta H
    Pulm Pharmacol Ther; 2008; 21(3):499-506. PubMed ID: 18282775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil Extracellular Traps Promote Angiogenesis: Evidence From Vascular Pathology in Pulmonary Hypertension.
    Aldabbous L; Abdul-Salam V; McKinnon T; Duluc L; Pepke-Zaba J; Southwood M; Ainscough AJ; Hadinnapola C; Wilkins MR; Toshner M; Wojciak-Stothard B
    Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2078-87. PubMed ID: 27470511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil extracellular traps are associated with inflammation in chronic airway disease.
    Wright TK; Gibson PG; Simpson JL; McDonald VM; Wood LG; Baines KJ
    Respirology; 2016 Apr; 21(3):467-75. PubMed ID: 26804470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia Increases the Potential for Neutrophil-mediated Endothelial Damage in Chronic Obstructive Pulmonary Disease.
    Lodge KM; Vassallo A; Liu B; Long M; Tong Z; Newby PR; Agha-Jaffar D; Paschalaki K; Green CE; Belchamber KBR; Ridger VC; Stockley RA; Sapey E; Summers C; Cowburn AS; Chilvers ER; Li W; Condliffe AM
    Am J Respir Crit Care Med; 2022 Apr; 205(8):903-916. PubMed ID: 35044899
    [No Abstract]   [Full Text] [Related]  

  • 19. Neutrophil Extracellular Traps Induce Trypsin Activation, Inflammation, and Tissue Damage in Mice With Severe Acute Pancreatitis.
    Merza M; Hartman H; Rahman M; Hwaiz R; Zhang E; Renström E; Luo L; Mörgelin M; Regner S; Thorlacius H
    Gastroenterology; 2015 Dec; 149(7):1920-1931.e8. PubMed ID: 26302488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil extracellular trap formation is regulated by CXCR2 in COPD neutrophils.
    Pedersen F; Waschki B; Marwitz S; Goldmann T; Kirsten A; Malmgren A; Rabe KF; Uddin M; Watz H
    Eur Respir J; 2018 Apr; 51(4):. PubMed ID: 29449427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.